Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Andie H. Djohan"'
Autor:
John T.Y. Soong, L.F. Tan, Rodney Y.H. Soh, W.B. He, Andie H. Djohan, H.W. Sim, T.C. Yeo, H.C. Tan, Mark Y.Y. Chan, C.H. Sia, M.L. Feng
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 55, Iss , Pp 101511- (2024)
Introduction: Frailty is associated with increased mortality in patients with percutaneous coronary intervention (PCI). Existing operationalized frailty measurement tools are limited and require resource intensive process. We developed and validated
Externí odkaz:
https://doaj.org/article/7a9057b60fc74897b91d92c93bcc27a9
Autor:
Qishi Zheng, Andie H. Djohan, Enghow Lim, Zee Pin Ding, Lieng H. Ling, Luming Shi, Edwin Shih-Yen Chan, Calvin Woon Loong Chin
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract The survival benefits of aortic valve replacement (AVR) in the different flow-gradient states of severe aortic stenosis (AS) is not known. A comprehensive search in PubMed/MEDLINE, Embase, Cochrane Library, CNKI and OpenGrey were conducted t
Externí odkaz:
https://doaj.org/article/dacb99ce9a174afa82bcf51a7fb8d7bc
Autor:
Amanda Jia Qi Ooi, Chloe Wong, Timothy Wei Ern Tan, Trina Priscilla Ng, Yao Neng Teo, Yao Hao Teo, Nicholas L. Syn, Andie H. Djohan, Yinghao Lim, Leonard L. L. Yeo, Benjamin Y. Q. Tan, Mark Yan-Yee Chan, Kian-Keong Poh, William K. F. Kong, Ping Chai, Tiong-Cheng Yeo, James W. Yip, Ivandito Kuntjoro, Ching-Hui Sia
Publikováno v:
European journal of clinical pharmacology. 78(10)
Transcatheter aortic valve replacement (TAVR) is increasingly carried out in patients with aortic valvular conditions. Atrial fibrillation (AF) is a common comorbidity among patients undergoing TAVR. Despite this, there remains a paucity of data and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d3ef6f80844accb2073efb34d625c73
https://pubmed.ncbi.nlm.nih.gov/35941300
https://pubmed.ncbi.nlm.nih.gov/35941300
Autor:
Andie H. Djohan, Jackie Chiu, Ching-Hui Sia, Benjamin W.L. Tung, Zhe Yan Ng, Koo Hui Chan, Mark Chan, William K.F. Kong, Chi-Hang Lee, Gavin Y. Ng, Adrian F. Low, Kian Keong Poh, Huay Cheem Tan, Tiong-Cheng Yeo, Poay Huan Loh
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 40
The clinical significance of coronary artery ectasia (CAE) is not yet fully understood. We aimed to examine differences in clinical and procedural characteristics, clinical management, and outcomes in patients with CAE undergoing primary percutaneous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::664e462cd489818b2ed8107e71d8bbcb
https://pubmed.ncbi.nlm.nih.gov/35618642
https://pubmed.ncbi.nlm.nih.gov/35618642
Publikováno v:
AsiaIntervention. 5:32-40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afec4a8f8a83207ad150c9c32e3f97d5
https://doi.org/10.4244/aij-d-18-00015
https://doi.org/10.4244/aij-d-18-00015
Publikováno v:
AsiaIntervention
Concomitant chronic kidney disease (CKD) and coronary artery disease (CAD) is known to have poor outcomes. With a thorough literature review, we discuss the pathophysiological basis behind accelerated atherosclerosis in CKD, and the role of percutane
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63217e28ddb58de5c222b0b74269a6b9
https://pubmed.ncbi.nlm.nih.gov/34912972
https://pubmed.ncbi.nlm.nih.gov/34912972